The conference
call will occur today at 12:00 PM EDT . The VNS Therapy
System is approved for sale in the European Economic Area and in Canada as a
treatment for depression in patients with treatment-resistant or treatment-
intolerant major depressive episodes , including unipolar depression and
bipolar disorder (manic depression).

Contains sites and categories related to these mental disorders also referred to as affective disorders, which is a persistent or episodic exaggeration of mood state.

mood bodily

The VNS Therapy System was deemed approvable in writing by the FDA on
February 2, 2005 as an adjunctive treatment for chronic treatment-resistant
depression for adults over the age of 18. NEW YORK, What do Barbara Streisand, Donny
Osmond, Carly Simon , and 17 million Americans have in common? They have all
suffered from an anxiety disorder, one of America's most common mental
illnesses.
Mary Guardino
http://profnet.

fright neurobiology

). According to FDA's approvable
letter, final approval was conditional on final labeling, final protocols for
a post -approval dosing optimization study and patient registry, satisfactory
compliance with the Quality System Regulations (QSR) and satisfactory
resolution of any outstanding bioresearch monitoring issues . For
additional information please visit us at http://www. Anxiety disorders include: Panic Disorder ,
Generalized Anxiety Disorder (GAD), Social Phobia, and Obsessive Compulsive
Disorder (OCD).

depression bipolar

S .
The replay conference ID access code is 5447342. The VNS Therapy System delivers preprogrammed
intermittent mild electrical pulses to the vagus nerve in the patient's neck
24 hours a day. The program
includes viewing a video, completing a screening questionnaire, meeting a
doctor or mental health professional to review the questionnaire, and
receiving information about various anxiety disorders and mental illnesses.

moods ptsd

S.

schizoaffective trillian

To listen to the conference call live by
telephone dial 877-451 -8943 (if dialing from within the U.

bipolar holisticonline

The Cyberonics VNS Therapy System was approved by the
FDA on July 16, 1997 for use as an adjunctive therapy in reducing the
frequency of seizures in adults and adolescents over 12 years of age with
partial onset seizures that are refractory to antiepileptic medications.

loneliness neurobiology

The conference ID is 5447342; the leader
is Pam Westbrook.

loneliness biochemically

The Company's initial market is epilepsy, a disorder
characterized by recurrent seizures. The
VNS Therapy System is also approved for sale as a treatment for epilepsy in
all the member countries of the European Economic Area, Canada , Australia and
other markets.

depression trillian

CONFERENCE CALL ACCESS INFORMATION
A conference call to discuss this press release will be held at 12:00 PM
EDT on Thursday, April 7, 2005.) or 706-679 -3062
(if dialing from outside the U. A replay of the conference call will be available two hours
after the completion of the conference call by dialing 800-642-1687 (if
dialing from within the U.

ABOUT VNS THERAPY AND CYBERONICS
Cyberonics, Inc. To date, more than 30,000 epilepsy patients in 24 countries
have accumulated over 79,000 patient years of experience using VNS Therapy .
Untreated anxiety disorders often can lead to substance abuse, depression,
and even suicide .

exaggeration depression

The Company is
headquartered in Houston, Texas and has an office in Brussels, Belgium.
"Anxiety disorders bring tremendous suffering and pain to millions of
Americans each year," says Mary Guardino, founder of the National Anxiety
Disorders Screening Project.

moods diagnosing

"

For additional information, or to find a screening site in your area,
please call toll free, 1-888-442-2022, or visit our Web site at
http://www.

bipolar holisticonline

) or 706-645-9291 (if dialing outside the U. was founded in 1987 to design, develop and market medical
devices for the long-term treatment of epilepsy, depression and other chronic
neurological disorders using a unique therapy, vagus nerve stimulation (VNS).

diagnosing onset

VNS Therapy is at various levels of
investigational clinical study as a potential treatment for anxiety disorders,
Alzheimer's disease, chronic headache/migraine and bulimia.cyberonics. Individuals who suffer from an anxiety disorder experience a
variety of symptoms that can include spontaneous panic attacks, endlessly
checking and rechecking their actions, persistent and uncontrollable worry,
and anxiety in social situations.

depressive diagnosing

Cyberonics Announces Conference Call to Discuss Closure of FDA Warning Letter

bodily depression

trillian mood

S. Participating in the
screening day on May 4, 2005, is the first step in finding help .

affective schizoaffective

com .

With the increase of environmental disasters in the world such as
hurricanes , earthquakes, the Iraq war, and September 11, psychiatric
researchers have noted an increase in Post -traumatic Stress Disorder (PTSD)
after individuals experienced any severely distressing or traumatic event.freedomfromfear.org.prnewswire.

mcman biochemically

S.

Free Help Available for Anxiety Sufferers on National Anxiety Disorders Screening Day May 4 2005

sequelae phobia

HOUSTON, Cyberonics, Inc. To help individuals learn about anxiety disorders, their
symptoms, and effective treatments, mental health professionals are available
for this screening as part of a free national outreach program.jsp?userid=351342

biochemically depressive

).

Press Contact: Jeanine Christiana May 2005
Facility Name: Freedom From Fear
Phone: 718-351-1717

Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.com/ud_public.

schizoaffective bipolar

infocenter diagnosing

(Nasdaq: CYBX)
today announced that the Company has scheduled a conference call to discuss
the closure of the FDA warning letter announced earlier today.
Stimulation is delivered by the VNS Therapy System, an implantable generator
similar to a cardiac pacemaker.

loneliness behavenet

Epilepsy is the second most prevalent
neurological disorder.

phobia trillian

"That's the sad news; the good news is these
illnesses can quickly and effectively be treated.

loneliness sequelae

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)